Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Lung cancer: Immune suppressant protein promotes tumor growth An immune suppressant protein expressed by non-small cell lung cancer cells (NSCLC) to facilitate tumor growth could be a valuable therapeutic target. NSCLC is often diagnosed at advanced stages, making treatment challenging. Therapies th...
Main Authors: | Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi, Seon Ye Kim, Jung-Eun Lee, Ki Jung Sung, Young Hoon Sung, Chan-Gi Pack, Min-kyo Jung, Buhm Han, Kunhee Kim, Woo Sung Kim, Soo Jeong Nam, Chang-Min Choi, Miyong Yun, Jae Cheol Lee, Jin Kyung Rho |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-08-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-019-0295-2 |
Similar Items
-
Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2
by: Dong Ha Kim, et al.
Published: (2021-07-01) -
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
by: Dong Ha Kim, et al.
Published: (2023-09-01) -
Efficacy of nano‐particulated, water‐soluble erlotinib against intracranial metastases of EGFR‐mutant lung cancer
by: Dong Ha Kim, et al.
Published: (2018-12-01) -
Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitors.
by: Yun Jung Choi, et al.
Published: (2013-01-01) -
Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors.
by: Yun Jung Choi, et al.
Published: (2019-01-01)